Assessing Potential Drug-Drug Interactions Between Dabigatran Etexilate and a P-Glycoprotein Inhibitor in Renal Impairment Populations Using Physiologically Based Pharmacokinetic Modeling

Potential Drug ◽

P Glycoprotein ◽

Implementation of a Physiologically Based Pharmacokinetic Modeling Approach to Guide Optimal Dosing Regimens for Imatinib and Potential Drug Interactions in Paediatrics

Frontiers in Pharmacology ◽

10.3389/fphar.2019.01672 ◽

2020 ◽

Vol 10 ◽

Cited By ~ 2

Author(s):

Jeffry Adiwidjaja ◽

Alan V. Boddy ◽

Andrew J. McLachlan

Keyword(s):

Drug Interactions ◽

Potential Drug ◽

Modeling Approach ◽

Optimal Dosing ◽

Physiologically Based ◽

Dosing Regimens

Application of Physiologically Based Pharmacokinetic Modeling to Predict Drug Exposure and Support Dosing Recommendations for Potential Drug‐Drug Interactions or in Special Populations: An Example Using Tofacitinib

The Journal of Clinical Pharmacology ◽

10.1002/jcph.1679 ◽

2020 ◽

Vol 60 (12) ◽

pp. 1617-1628

Author(s):

Susanna Tse ◽

Martin E. Dowty ◽

Sujatha Menon ◽

Pankaj Gupta ◽

Sriram Krishnaswami

Keyword(s):

Drug Interactions ◽

Drug Exposure ◽

Special Populations ◽

Potential Drug ◽

Application of Physiologically Based Pharmacokinetic Modeling in Understanding Bosutinib Drug-Drug Interactions: Importance of Intestinal P-Glycoprotein

Drug Metabolism and Disposition ◽

10.1124/dmd.118.080424 ◽

2018 ◽

Vol 46 (8) ◽

pp. 1200-1211 ◽

Cited By ~ 4

Author(s):

Shinji Yamazaki ◽

Cho-Ming Loi ◽

Emi Kimoto ◽

Chester Costales ◽

Manthena V. Varma

Keyword(s):

Drug Interactions ◽

P Glycoprotein ◽

Physiologically Based Pharmacokinetic Modeling Approach to Predict Drug‐Drug Interactions With Ethionamide Involving Impact of Genetic Polymorphism on FMO3

The Journal of Clinical Pharmacology ◽

10.1002/jcph.1378 ◽

2019 ◽

Vol 59 (6) ◽

pp. 880-889 ◽

Cited By ~ 1

Author(s):

Phuong Thi Thu Nguyen ◽

Md Masud Parvez ◽

Min Jung Kim ◽

Sung Eun Yoo ◽

Sangzin Ahn ◽

...

Keyword(s):

Genetic Polymorphism ◽

Drug Interactions ◽

Modeling Approach ◽

Physiologically based pharmacokinetic modeling to predict complex drug-drug interactions: a case study of AZD2327 and its metabolite, competitive and time-dependent CYP3A inhibitors

Biopharmaceutics & Drug Disposition ◽

10.1002/bdd.1962 ◽

2015 ◽

Vol 36 (8) ◽

pp. 507-519 ◽

Cited By ~ 4

Author(s):

Jian Guo ◽

Diansong Zhou ◽

Yan Li ◽

Bui H. Khanh

Keyword(s):

Drug Interactions ◽

Time Dependent ◽

Physiologically Based ◽

Complex Drug

Pain Chemogenomics Knowledgebase (Pain-CKB) for Systems Pharmacology Target Mapping and Physiologically Based Pharmacokinetic Modeling Investigation of Opioid Drug–Drug Interactions

ACS Chemical Neuroscience ◽

10.1021/acschemneuro.0c00372 ◽

2020 ◽

Vol 11 (20) ◽

pp. 3245-3258

Author(s):

Mingzhe Shen ◽

Maozi Chen ◽

Tianjian Liang ◽

Siyi Wang ◽

Ying Xue ◽

...

Keyword(s):

Drug Interactions ◽

Systems Pharmacology ◽

Physiologically‐Based Pharmacokinetic Modeling for Predicting Drug Interactions of a Combination of Olanzapine and Samidorphan

CPT Pharmacometrics & Systems Pharmacology ◽

10.1002/psp4.12488 ◽

2020 ◽

Vol 9 (2) ◽

pp. 106-114 ◽

Cited By ~ 2

Author(s):

Lei Sun ◽

Lisa Moltke ◽

Karen Rowland Yeo

Keyword(s):

Drug Interactions ◽

Assessing drug distribution in tissues expressing P-glycoprotein through physiologically based pharmacokinetic modeling: model structure and parameters determination

Theoretical Biology and Medical Modelling ◽

10.1186/1742-4682-6-2 ◽

2009 ◽

Vol 6 (1) ◽

pp. 2 ◽

Cited By ~ 25

Author(s):

Frédérique Fenneteau ◽

Jacques Turgeon ◽

Lucie Couture ◽

Véronique Michaud ◽

Jun Li ◽

...

Keyword(s):

Drug Distribution ◽

Model Structure ◽

P Glycoprotein ◽

Physiologically based pharmacokinetic modeling of disposition and drug–drug interactions for atorvastatin and its metabolites

European Journal of Pharmaceutical Sciences ◽

10.1016/j.ejps.2015.06.019 ◽

2015 ◽

Vol 77 ◽

pp. 216-229 ◽

Cited By ~ 18

Author(s):

Tao Zhang

Keyword(s):

Drug Interactions ◽

Physiologically based pharmacokinetic modelling andin vivo[I]/Kiaccurately predict P-glycoprotein-mediated drug-drug interactions with dabigatran etexilate

British Journal of Pharmacology ◽

10.1111/bph.12533 ◽

2014 ◽

Vol 171 (4) ◽

pp. 1043-1053 ◽

Cited By ~ 28

Author(s):

Yuansheng Zhao ◽

Zhe-Yi Hu

Keyword(s):

Drug Interactions ◽

Dabigatran Etexilate ◽

Pharmacokinetic Modelling ◽

Physiologically Based Pharmacokinetic Modelling ◽

P Glycoprotein ◽